Satu Långström
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Satu Långström has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Ulla Wartiovaara-Kautto
4 shared publications- Jari Petäjä
Director, Department of Pediatrics and Gynecology Helsinki University Central Hospital, Finland
3 shared publications Kaija Peltola
3 shared publicationsLeena Mildh
3 shared publications- Markku Heikinheimo
University of Helsinki
3 shared publications Paula Rautiainen
3 shared publications
Latest Publications
- 1 December 2008
- Vol. 100 (6) , 1207-8
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery.
- 1 December 2008
- Vol. 100 (6) , 1207-8
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery.
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 100 (12) , 1207-1208
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 100 (12) , 1207-1208
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 99 (04) , 791-792
Thrombin regulation in neonates undergoing cardiopulmonary bypass
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 99 (04) , 791-792
Thrombin regulation in neonates undergoing cardiopulmonary bypass
- 1 August 2006
- Vol. 96 (2) , 142-8
Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
Exchange transfusion (ET) with adult blood is a standard procedure for neonates with severe hyperbilirubinemia. How ET affects newborn coagulation system remains, however, largely unknown. Thus, we prospectively evaluated the effect of ET on thrombin formation and coagulation profile in 18 newborns (22 ETs). Prothrombin fragment F1+2 and thrombin-antithrombin complexes increased considerably during ET while platelets were significantly reduced. Protein C increased less (p < 0.001) and factor VIIIc more (p < 0.001) than expected based on their levels in the infused blood. Further, in vitro thrombin generation initiated by 5 pM tissue factor was analysed. Before the first ET, newborn endogenous thrombin potential (ETP) and thrombin peak remained at approximately 60% of adult control plasma levels, but the lag time to thrombin burst in newborn plasma was approximately 45% shorter than the lag time in adult plasma. At the end of the first ET, the thrombin burst still started approximately 35% earlier in newborn than adult plasma, whereas ETP and thrombin peak were increased to > 90% of adult levels. ETP and peak remained elevated at adult levels until the beginning of the second ET. APC-induced reductions in newborn ETP remained unaltered throughout the first ET. The reductions of ETP by APC were less pronounced in newborn than adult plasma (p < 0.0001). We conclude that ET is associated with multiple procoagulant changes and increased in vivo thrombin formation. This ET-induced procoagulant challenge may be of clinical significance in sick newborns already prone to bleeding and thrombotic complications.
- 1 August 2006
- Vol. 96 (2) , 142-8
Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
Exchange transfusion (ET) with adult blood is a standard procedure for neonates with severe hyperbilirubinemia. How ET affects newborn coagulation system remains, however, largely unknown. Thus, we prospectively evaluated the effect of ET on thrombin formation and coagulation profile in 18 newborns (22 ETs). Prothrombin fragment F1+2 and thrombin-antithrombin complexes increased considerably during ET while platelets were significantly reduced. Protein C increased less (p < 0.001) and factor VIIIc more (p < 0.001) than expected based on their levels in the infused blood. Further, in vitro thrombin generation initiated by 5 pM tissue factor was analysed. Before the first ET, newborn endogenous thrombin potential (ETP) and thrombin peak remained at approximately 60% of adult control plasma levels, but the lag time to thrombin burst in newborn plasma was approximately 45% shorter than the lag time in adult plasma. At the end of the first ET, the thrombin burst still started approximately 35% earlier in newborn than adult plasma, whereas ETP and thrombin peak were increased to > 90% of adult levels. ETP and peak remained elevated at adult levels until the beginning of the second ET. APC-induced reductions in newborn ETP remained unaltered throughout the first ET. The reductions of ETP by APC were less pronounced in newborn than adult plasma (p < 0.0001). We conclude that ET is associated with multiple procoagulant changes and increased in vivo thrombin formation. This ET-induced procoagulant challenge may be of clinical significance in sick newborns already prone to bleeding and thrombotic complications.